These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 20590708)

  • 41. Prospective randomized comparison of sodium tetradecyl sulfate and polidocanol as variceal sclerosing agents.
    Bhargava DK; Singh B; Dogra R; Dasarathy S; Sharma MP
    Am J Gastroenterol; 1992 Feb; 87(2):182-6. PubMed ID: 1734694
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The Troyanov-Trendelenburg operation in combination with sclerotherapy as an effective method of outpatient treatment of varicose disease].
    Khubulaeva GG; Sazonov AB; Sazonov AA
    Vestn Khir Im I I Grek; 2007; 166(6):41-3. PubMed ID: 18411740
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long term results of compression sclerotherapy.
    Labas P; Ohradka B; Cambal M; Reis R; Fillo J
    Bratisl Lek Listy; 2003; 104(2):78-81. PubMed ID: 12839217
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Implication of foam sclerosant inactivation by human whole blood in a laboratory setting.
    Dabbs EB; Dos Santos SJ; Mainsiouw LE; Sheikh AA; Gkantiragas A; Shiangoli I; Watkins MR; Nemchand JL; Whiteley MS
    Phlebology; 2018 Jun; 33(5):338-343. PubMed ID: 28516808
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Injection sclerotherapy for varicose veins.
    Tisi PV; Beverley C; Rees A
    Cochrane Database Syst Rev; 2006 Oct; (4):CD001732. PubMed ID: 17054141
    [TBL] [Abstract][Full Text] [Related]  

  • 46. FDA-approved sodium tetradecyl sulfate (STS) versus compounded STS for venous sclerotherapy.
    Almeida JI; Raines JK
    Dermatol Surg; 2007 Sep; 33(9):1037-44; discussion 1044. PubMed ID: 17760594
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A meta-analysis of prophylactic endoscopic sclerotherapy for esophageal varices.
    Fardy JM; Laupacis A
    Am J Gastroenterol; 1994 Nov; 89(11):1938-48. PubMed ID: 7942715
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Double-blind prospective comparative trial between foamed and liquid polidocanol and sodium tetradecyl sulfate in the treatment of varicose and telangiectatic leg veins.
    Rao J; Wildemore JK; Goldman MP
    Dermatol Surg; 2005 Jun; 31(6):631-5; discussion 635. PubMed ID: 15996411
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Microfoam sclerotherapy.
    Redondo P; Cabrera J
    Semin Cutan Med Surg; 2005 Dec; 24(4):175-83. PubMed ID: 16387261
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The use of foam sclerotherapy for the treatment of head and neck vascular malformations.
    Rehman KU; Sittampalam G; McCafferty I; Monaghan A
    Br J Oral Maxillofac Surg; 2009 Dec; 47(8):631-2. PubMed ID: 19375203
    [No Abstract]   [Full Text] [Related]  

  • 51. Studies in sclerotherapy: I. Comparison of sodium tetradecyl sulphate (STS) with absolute alcohol (AA) as sclerosants in the treatment of esophageal varices.
    Chawla Y; Dilawari JB
    J Clin Gastroenterol; 1990 Aug; 12(4):378-80. PubMed ID: 2398244
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hyperosmolar versus detergent sclerosing agents in sclerotherapy. Effect on distal vessel obliteration.
    Sadick NS
    J Dermatol Surg Oncol; 1994 May; 20(5):313-6. PubMed ID: 8176042
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy and safety of endovenous foam sclerotherapy: meta-analysis for treatment of venous disorders.
    Rathbun S; Norris A; Stoner J
    Phlebology; 2012 Apr; 27(3):105-17. PubMed ID: 22349606
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sclerosants for variceal sclerotherapy: a critical appraisal.
    Sarin SK; Kumar A
    Am J Gastroenterol; 1990 Jun; 85(6):641-9. PubMed ID: 2191592
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Complications of sclerotherapy for 75 head and neck venous malformations.
    Castrén E; Aronniemi J; Klockars T; Pekkola J; Lappalainen K; Vuola P; Salminen P; Pitkäranta A
    Eur Arch Otorhinolaryngol; 2016 Apr; 273(4):1027-36. PubMed ID: 25731642
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Localized hypertrichosis after sclerotherapy.
    Oh TS; Kim Y; Song HJ
    Dermatol Surg; 2010 Jun; 36 Suppl 2():1064-5. PubMed ID: 20590714
    [No Abstract]   [Full Text] [Related]  

  • 57. Evaluation of published reports of foam sclerotherapy: what do we know conclusively?
    Myers KA; Roberts S
    Phlebology; 2009 Dec; 24(6):275-80. PubMed ID: 19952384
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Consensus for sclerotherapy.
    Weiss MA; Hsu JT; Neuhaus I; Sadick NS; Duffy DM
    Dermatol Surg; 2014 Dec; 40(12):1309-18. PubMed ID: 25418805
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Polidocanol: the perfect "solution".
    Weiss RA
    J Dermatol Surg Oncol; 1994 Jul; 20(7):465. PubMed ID: 8034841
    [No Abstract]   [Full Text] [Related]  

  • 60. [Sclerotherapy of small pelvis varicosis].
    Sukovatykh BS; Belikov LN; Rodionov OA; Rodionova IG; Sukovatykh MB; Gorbachev IuI
    Angiol Sosud Khir; 2004; 10(1):101-5. PubMed ID: 15163996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.